Medical Science Liaison – Oncology, UK - Remote (Travel across the UK is required 60-80%) with some visits to our UK offices

About the Company

Pharmanovia is a global specialty pharmaceutical company focused on innovative specialty medicines and trusted established brands. We partner with biotechnology innovators and pharmaceutical companies to bring important medicines to patients, while supporting established brands across more than 160 markets. Our model combines scientific, medical, regulatory, market access, supply chain and commercial expertise. We are building a targeted specialty portfolio within oncology, including oncology supportive care, as a major area of strategic development, alongside selected opportunities in rare disease, neurology and other specialty areas where there is a clear scientific rationale and unmet patient need.

About the Role

We are looking for an experienced, science-driven Medical Science Liaison (MSL) to join our Medical Affairs team and play a key role in supporting the development and growth of our oncology portfolio in the UK. Reporting to the Medical Director, UK & Nordics, you will be responsible for delivering high-quality, non-promotional scientific engagement with healthcare professionals and other relevant external stakeholders. You will translate UK and global Medical Affairs strategy into focused field execution within your assigned territory, while contributing to national priorities and launch readiness. The role has a particular focus on oncology and oncology supportive care, including priority NCEs, biologics and value-added medicine opportunities. You will develop trusted peer-to-peer relationships with oncologists and other relevant specialists, generate actionable medical insights, identify patient-pathway and evidence gaps, support evidence-generation activities and contribute to scientific readiness before, during and after launch. This is a highly externally focused and hands-on role. You will spend significant time in the field, prioritising scientific engagement based on patient need and Medical Affairs priorities rather than activity volume. You will work closely with Medical Affairs and cross-functional colleagues while maintaining independent medical judgement, scientific integrity and the non-promotional character of Medical Affairs.

Responsibilities

• Build and maintain trusted peer-to-peer relationships with priority oncology healthcare professionals, including oncologists, investigators, pharmacists, specialist nurses, pathologists and other relevant scientific stakeholders.
• Provide credible, objective and balanced scientific exchange on disease areas, clinical evidence, treatment pathways and appropriate use of Pharmanovia medicines within approved non-promotional processes.
• Maintain deep and current scientific expertise in oncology, including priority tumour types, oncology supportive care, biomarkers, diagnostics, standards of care, patient pathways and relevant clinical evidence.
• Develop and execute a focused territory plan aligned with the UK Medical Affairs strategy, prioritising stakeholder engagement according to scientific relevance, patient need, asset strategy and healthcare-system priorities.
• Support pre-launch, launch and post-launch Medical Affairs activities for priority oncology assets, ensuring agreed field activities and launch-readiness milestones are delivered effectively.
• Contribute to launch readiness through stakeholder mapping, scientific exchange, patient-pathway assessment, congresses, advisory boards, medical education, insight generation and internal readiness activities.
• Generate high-quality and actionable medical insights from external scientific engagement, identifying unmet needs, evidence gaps, access barriers, changes in clinical practice and competitor developments.
• Translate field insights into meaningful recommendations, ensuring relevant intelligence informs medical strategy, evidence planning, launch readiness, access activities and cross-functional decision-making.
• Identify patient-pathway and evidence gaps, including barriers relating to patient identification, diagnosis, biomarker testing, referral, treatment and supportive care, and communicate these to relevant internal teams.
• Support evidence-generation activities, including real-world evidence, registries, investigator-initiated research, Phase IV studies and other post-authorisation studies or scientific collaborations.
• Support Clinical Development activities, including investigator and site identification, feasibility, recruitment insights, patient-journey considerations and communication of approved study results.
• Support scientific education, congress activity and advisory boards, ensuring all activity is scientifically accurate, balanced, relevant to UK clinical practice and aligned with agreed Medical Affairs objectives.
• Provide scientific training to internal colleagues on disease areas, clinical evidence, patient pathways and appropriate product information within the scope of the role.
• Work collaboratively with Market Access/HEOR, Commercial, Marketing, Clinical Development, Regulatory, Pharmacovigilance, Medical Information, Quality and Compliance, ensuring medical insights contribute appropriately to integrated launch and lifecycle plans while maintaining Medical Affairs independence.
• Support UK market access activities, including NICE, SMC, AWMSG and relevant NHS discussions, by providing accurate scientific interpretation of clinical evidence, patient pathways, unmet need and treatment impact within agreed responsibilities.
• Maintain high standards of Medical Affairs documentation and governance, accurately recording external engagements, insights, follow-up and commitments in approved systems.
• Ensure full compliance with applicable UK and European legislation, industry codes, company policies, pharmacovigilance requirements, quality standards and Medical Affairs procedures, including the prompt reporting of adverse events, special situations and product complaints.